XML 83 R71.htm IDEA: XBRL DOCUMENT v3.21.1

Collaboration Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd (Narrative) (Details) - 3SBio License $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Aggregate amount of upfront and milestone-based payments	$ 7.0
Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform	$ 15.0

X

- Definition

Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform

+ References

No definition available.

+ Details

Name:	selb_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform
Namespace Prefix:	selb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Aggregate Amount Of Upfront And Milestone Based Payments Paid

+ References

No definition available.

+ Details

Name:	selb_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid
Namespace Prefix:	selb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=selb_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: